Risch, however, is sharply criticizing Fauci’s approach to evaluating the drug’s effectiveness, arguing that repeated trials and tests have shown that it is markedly effective at treating COVID-19 so long as it is administered properly.
Risch, a professor of epidemiology and the director of Yale’s Molecular Cancer Epidemiology Laboratory, has been pushing for the drug’s use in the fight against the coronavirus for months. Last week in a Newsweek op-ed he called HCQ “the key to defeating COVID-19,” claiming its use — particularly when administered with one of two antibiotics and the nutritional supplement zinc — has been “shown to be highly effective” in treating high-risk coronavirus patients.
